The National Diabetes Audit (NDA) is a major national clinical audit, which measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales (Diabetes UK)
Diabetes News
Category: Audits
Paediatric diabetes – Report on care and outcomes 2021/22 (NPDA)
Based on data from 33,251 children and young people receiving care from a PDU in 2021/22 in England and Wales, it found that the increase in incidence of Type 1 diabetes observed in the first year of the COVID-19 pandemic was followed by a continuing increase in the numbers newly diagnosed with the condition in 2021/22 Download report (HQIP)
Type 2 diabetes in adults
Quality standard [QS209]Published: 02 March 2023 (NICE)
Type 1 diabetes in adults
Quality standard [QS208]Published: 02 March 2023 (NICE)
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773] (NICE)
Introduction and Methodology: Standards of Care in Diabetes—2023
The American Diabetes Association (ADA) “Standards of Care in Diabetes,” referred to here as the Standards of Care, is intended to provide clinicians, researchers, policy makers, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care (Diabetes Care)
Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England
The substantial number of people under 40 years of age with type 2 diabetes, are more likely to have characteristics associated with inequalities and are less likely to achieve HbA1c targets and receive recommended care processes. These findings highlight the need to consider novel approaches to service provision for this high-risk group (Diabetic Medicine)
The English National Health Service Diabetes Prevention Programme (NHS DPP): A scoping review of existing evidence
The evidence is accumulating on NHS DPP uptake and retention most, with emerging evidence on programme outcomes (such as weight loss and HbA1c). More evidence is warranted on stakeholder experience to decipher how to overcome low initial and long-term engagement reported by the current evidence base (Diabetic Medicine)
Launch of the ABCD audit for the Omnipod insulin pump
ABCD is pleased to announce the launch of the ABCD International Omnipod audit and would like to invite you to take part (ABCD)
Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit
Remission of type 2 diabetes was generally infrequent in routine care settings but may be a reasonable goal for a subset of people who lose a significant amount of weight shortly after diagnosis (Diabetes Care)
Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period
There remains a wide variation in mortality rate of people with diabetes between general practices in UK. The mortality rate and life years lost for people with diabetes vs non-diabetes individuals have remained stable in recent years, while mortality rates for the general population have fallen (Diabetes Therapy)
Standards of Medical Care in Diabetes—2022
Professional Practice Committee: Standards of Medical Care in Diabetes—2022 (Diabetes Care)
Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records
Changes in the composition of excess risk and hospitalisation burden in those with diabetes means that preventative and clinical measures should evolve to reflect the diverse set of causes that are driving persistent excess hospitalisation in those with diabetes (The Lancet Diabetes & Endocrinology)
National Diabetes Audit, Non-Diabetic Hyperglycaemia, 2020-21, Diabetes Prevention Programme, Data Release
This short report uses data collected from GP practices alongside the National Diabetes Audit (NDA) for the period January 2020 to March 2021 inclusive. This report is for England only (NHS Digital)
Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales
People with diabetes who have fewer routine care processes have higher mortality (Diabetes, Obesity and Metabolism)
Young People with Type 2 Diabetes, 2019-20
The National Diabetes Audit (NDA) and the National Paediatric Diabetes Audit (NPDA) provide a comprehensive view of diabetes care in England and Wales (NHS Digital)
National Diabetes Audit, 2019-20 , Type 1 Diabetes
This is the first NDA report dedicated to people with type 1 diabetes (NHS Digital)
Type 1 diabetes in adults: diagnosis and management (update)
You can now review and comment on this draft guideline. The consultation closes on 19 May 2021 at 5pm (NICE)
Type 1 diabetes in adults: diagnosis and management (update)
In development [GID-NG10159] Expected publication date: 21 July 2021. A list of downloadable documents created during development (NICE)
The All‐Wales Medicines Strategy Group: 18 years’ experience of a National Medicines Optimisation Committee
Since 2002, AWMSG has acted as a national medicines optimisation committee in Wales. From the outset, pharmacists and clinical pharmacologists have collaborated closely and shared their complementary expertise to make a much greater contribution to the safe, effective, and cost‐effective use of medicines than either group could have achieved by working separately (British Journal of Clinical Pharmacology)
- 1
- 2
- 3
- …
- 9
- Next Page »